Reports
Reports
Sale
The global graft versus host disease treatment market size is expected to grow in the forecast period of 2024-2032 at a CAGR of 8.50%.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
A significant portion of adults and children surviving for more than 100 days after transplants are affected by chronic graft versus host disease (cGvHD), which is propelling the demand for immunosuppressive medications from healthcare units. The cGvHD can be lethal and the patients requires great care in order to survive.
Moreover, cGvHD can appear after few days, or after several years post-transplant. It might occur in skin, liver, mouth, or lungs, and the symptoms are usually vague. Hence, over the forecast period, the anticipated increase in advancements in healthcare units to improve the diagnosis of this illness is likely to aid the graft versus host disease treatment market growth in the coming years.
The United States is the highest spender on healthcare all over the world. Over the forecast period, the increasing healthcare awareness and stringent government regulations aimed towards bolstering the medical facilities to augment cell therapy and cancer treatment are likely to propel the market growth. In addition to this, the growing geriatric population and increasing prevalence of lifestyle related issues such as obesity, are anticipated to accelerate the market growth in the region.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Graft versus host disease refers to a complication pertaining to allogeneic stem cell transplantation in which the body of a human treats the donated stem cells as foreign objects leading to an attack against them. It is a potentially serious disease which is usually caused due to the significant differences in the body of the host and the donor and requires treatment.
Based on type, the market can be segmented into:
By treatment, the graft versus host disease treatment market has been divided into:
The significant distribution channels included in the market are as follows:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The rising frequency of allogeneic transplantations among adults and geriatrics is leading to an escalation of graft versus host disease. Over the forecast period, the anticipated increase in the cases of blood cancers such as leukaemia and lymphoma are likely to propel the risk of graft versus host disease. This will foster the need for an efficient treatment plan to counter it.
Meanwhile, the emerging online-pharmacies are proving to be a boon for the graft versus host disease treatment market by providing comfort of door-step-delivery to the patients. Over the forecast period, the anticipated increase in research and development activities by the major pharmaceutical and biopharmaceutical industries are likely to lead to progressive product innovations, thereby, navigating the market growth in a positive direction.
The increasing number of players in the field of medical research, coupled with the favourable policies of the government of the emerging economies are likely to provide impetus to the market in the coming years.
The report gives a detailed analysis of the following key players in the global graft versus host disease treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter’s five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Treatment |
|
Breakup by Distribution Channels |
|
Breakup by Region |
|
Market Dynamics |
|
Competitive Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Region
7 Opportunities and Challenges in the Market
8 Global Graft Versus Host Disease (GvHD) Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Graft versus Host Disease (GvHD) Treatment Historical Market (2018-2023)
8.3 Global Graft Versus Host Disease (GvHD) Treatment Market Forecast (2024-2032)
8.4 Global Graft Versus Host Disease (GvHD) Treatment Market by Type
8.4.1 Acute Graft Versus Host Disease (aGvHD)
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Chronic Graft Versus Host Disease (cGvHD)
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.5 Global Graft Versus Host Disease (GvHD) Treatment Market by Treatment
8.5.1 mTOR Inhibitors
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.2 TNFα Inhibitors
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.3 SOT Therapies
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.4 Corticosteroids
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Stem Cell Treatments
8.5.5.1 Historical Trend (2018-2023)
8.5.5.2 Forecast Trend (2024-2032)
8.5.6 Others
8.6 Global Graft Versus Host Disease (GvHD) Treatment Market by Distribution Channels
8.6.1 Hospital Pharmacies
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Retail Pharmacies
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Online Pharmacies
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.7 Global Graft Versus Host Disease (GvHD) Treatment Market by Region
8.7.1 North America
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Europe
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Asia Pacific
8.7.3.1 Historical Trend (2018-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.7.4 Latin America
8.7.4.1 Historical Trend (2018-2023)
8.7.4.2 Forecast Trend (2024-2032)
8.7.5 Middle East and Africa
8.7.5.1 Historical Trend (2018-2023)
8.7.5.2 Forecast Trend (2024-2032)
9 North America Graft Versus Host Disease (GvHD) Treatment Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Graft Versus Host Disease (GvHD) Treatment Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Graft Versus Host Disease (GvHD) Treatment Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Graft Versus Host Disease (GvHD) Treatment Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Graft Versus Host Disease (GvHD) Treatment Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Incyte Corporation
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Sanofi
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Mesoblast Ltd
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 AbbVie Inc.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 Bristol Myers Squibb
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.7 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Graft Versus Host Disease (GvHD) Treatment Market: Key Industry Highlights, 2018 and 2032
2. Global Graft Versus Host Disease (GvHD) Treatment Historical Market: Breakup by Type (USD Million), 2018-2023
3. Global Graft Versus Host Disease (GvHD) Treatment Market Forecast: Breakup by Type (USD Million), 2024-2032
4. Global Graft versus Host Disease (GvHD) Treatment Historical Market: Breakup by Treatment (USD Million), 2018-2023
5. Global Graft Versus Host Disease (GvHD) Treatment Market Forecast: Breakup by Treatment (USD Million), 2024-2032
6. Global Graft versus Host Disease (GvHD) Treatment Historical Market: Breakup by Distribution Channels (USD Million), 2018-2023
7. Global Graft Versus Host Disease (GvHD) Treatment Market Forecast: Breakup by Distribution Channels (USD Million), 2024-2032
8. Global Graft versus Host Disease (GvHD) Treatment Historical Market: Breakup by Region (USD Million), 2018-2023
9. Global Graft Versus Host Disease (GvHD) Treatment Market Forecast: Breakup by Region (USD Million), 2024-2032
10. North America Graft versus Host Disease (GvHD) Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
11. North America Graft Versus Host Disease (GvHD) Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Europe Graft versus Host Disease (GvHD) Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
13. Europe Graft Versus Host Disease (GvHD) Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Asia Pacific Graft versus Host Disease (GvHD) Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
15. Asia Pacific Graft Versus Host Disease (GvHD) Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Latin America Graft versus Host Disease (GvHD) Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
17. Latin America Graft Versus Host Disease (GvHD) Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Middle East and Africa Graft versus Host Disease (GvHD) Treatment Historical Market: Breakup by Country (USD Million), 2018-2023
19. Middle East and Africa Graft Versus Host Disease (GvHD) Treatment Market Forecast: Breakup by Country (USD Million), 2024-2032
20. Global Graft Versus Host Disease (GvHD) Treatment Market Structure.
The market is estimated to grow at a CAGR of 3.50% between 2024 and 2032.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The major drivers of the market include the increasing prevalence of allogeneic transplantations, rising cases of blood cancer, and increasing healthcare awareness.
The thriving online-pharmacies is likely to be a key trend in the market.
Acute graft versus host disease (aGvHD) and chronic graft versus host disease (cGvHD) are the different types based on which the market has been divided.
The segments of market based on treatment are mTOR inhibitors, TNFα inhibitors, SOT therapies, corticosteroids, and stem cell treatments, among others.
Hospital pharmacies, retail pharmacies, and online pharmacies are the significant distribution channels included in the market report.
The major players in the industry are Incyte Corporation, Sanofi, Mesoblast Ltd, AbbVie Inc., and Bristol Myers Squibb, among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.